If you take antidepressants, benzodiazepines or other medicines for anxiety, tell the medical cannabis clinic before any prescription decision. This is not a reason to panic and it is not a sign you have done anything wrong. It is a normal safety step.
The prescriber and pharmacist need to see the whole picture: your current medicines, over-the-counter products, supplements, CBD products, alcohol use, non-prescribed cannabis use, previous side effects and mental-health history. That is how they can judge whether a cannabis-based medicinal product is suitable to consider, what risks need review, and when another route is safer.
This article is general UK patient information. It is not medical advice, it is not an interaction checker, and it is not telling you to stop or change any medicine. If you are planning a consultation, start with the MCPH patient guide and read the wider safety guide on medical cannabis and medication interactions.
The short answer
Medical cannabis can affect alertness, mood, anxiety, sleep, judgement and coordination. NHS medical cannabis guidance also says CBD and THC can affect how other medicines work. That is why antidepressants and anxiety medicines need to be disclosed.
The main patient action is simple: give the clinic a complete medicine and mental-health history. Do not stop, reduce, add, swap or alter prescribed medicines on the basis of an article. Antidepressants, benzodiazepines and some anxiety medicines can need careful withdrawal or review if changes are ever needed, and that sits with the prescribing clinician.
This is especially important if you take:
- an SSRI such as sertraline, fluoxetine, citalopram, escitalopram or paroxetine
- an SNRI such as duloxetine or venlafaxine
- mirtazapine or another antidepressant used for mood, sleep or anxiety
- a benzodiazepine such as lorazepam, diazepam, clonazepam or alprazolam
- pregabalin, gabapentin, propranolol, sleeping tablets, antipsychotics or mood stabilisers
- over-the-counter CBD, herbal products such as St John’s wort, alcohol or non-prescribed cannabis
The article cannot say whether any combination is suitable for you. It can help you prepare the right disclosure.
Why SSRIs, SNRIs and mirtazapine matter
Antidepressants are not all the same, but they are all relevant to a medical cannabis assessment. SSRIs, SNRIs and mirtazapine may be used for depression, anxiety, panic symptoms, pain, sleep or mixed symptoms. The clinic needs to know why you take them, how long you have taken them, whether they help, and whether they have caused side effects.
The concern is not just a technical drug interaction. It is also the real-world overlap in symptoms and side effects. A patient taking an antidepressant may already be dealing with anxiety, low mood, poor sleep, dizziness, nausea, concentration problems or changes in appetite. Medical cannabis can also be linked with tiredness, dizziness, mood changes, feeling high, hallucinations, anxiety or suicidal thoughts in some people.
If those symptoms appear or change, the prescriber needs enough context to work out what might be happening. Is it the underlying condition, a current medicine, alcohol, non-prescribed cannabis, a new cannabis-based product, withdrawal from something else, or another health issue? A public article cannot separate those safely.
Benzodiazepines and sedating anxiety medicines
Benzodiazepines and other sedating medicines need particular care because impairment can stack up. Lorazepam, diazepam and clonazepam can cause sleepiness, dizziness, slower reactions, memory problems or reduced coordination. THC-containing medical cannabis can also affect alertness and coordination.
That does not mean every patient taking an anxiety medicine is automatically unsuitable. It does mean the prescriber needs to assess sedation, falls risk, driving, work, caring responsibilities, alcohol use and any other medicines that affect the central nervous system.
Tell the clinic if you take a benzodiazepine every day, only in panic attacks, at night, after a crisis, or as part of a tapering plan from another clinician. Pattern of use matters. So does the reason for the medicine: panic, trauma symptoms, insomnia, muscle spasm, seizure history, severe anxiety or another diagnosis.
Do not stop benzodiazepines suddenly because of something you read online. If a medicine plan ever needs review, that must be handled by the responsible clinician.
Mental-health and substance-use history to disclose
Interaction checks are only one part of this topic. Mental-health screening matters just as much.
Be honest about:
- panic attacks or cannabis-triggered panic
- severe anxiety, severe depression, suicidal thoughts or self-harm history
- psychosis, hallucinations, paranoia, schizophrenia history, bipolar disorder or mania
- substance-use concerns, including alcohol, non-prescribed cannabis, sedatives or stimulants
- previous adverse reactions to cannabis, CBD, antidepressants or anxiety medicines
- family history where the clinician asks for it
- current stress, sleep disruption, safeguarding concerns or unstable circumstances
RCPsych warns that cannabis can affect mental health, including psychosis and dependence risk. That does not mean every patient with anxiety or depression is unsuitable. It means the assessment must be honest and specific, especially where THC, panic, psychosis history or substance-use history are part of the picture.
For more background, read MCPH’s guide to medical cannabis and mental health screening and THC side effects and impairment.
What to take to a consultation
Bring a plain medicine list. It does not need to be perfect medical prose. It should be complete.
Include:
- medicine names and strengths if you know them
- how often you take each medicine, as prescribed
- who prescribes each medicine
- over-the-counter medicines, supplements and CBD products
- alcohol and non-prescribed cannabis use
- medicines recently stopped or changed by a clinician
- allergies, previous side effects and adverse cannabis reactions
- the symptoms each medicine is meant to help
The Summary Care Record from the GP surgery may help show current and recent medicines. If the clinic needs more mental-health notes or specialist letters, it can ask. This is a records step, not a request to persuade a GP about medical cannabis.
Safety issues to ask about
Useful questions are practical:
- Do any of my antidepressants, anxiety medicines or supplements need pharmacist review?
- Which side effects should I report quickly?
- How do you monitor sedation, dizziness, panic, low mood or feeling unusually impaired?
- What should I do if anxiety, paranoia, hallucinations or suicidal thoughts appear or worsen?
- How do alcohol and non-prescribed cannabis affect the safety review?
- How does this affect driving, work, caring duties or other safety-critical tasks?
- Who do I contact if another clinician changes one of my medicines?
For driving, keep the boundary strict. A prescription is not blanket driving clearance, and an article cannot decide whether you are fit to drive. If you feel impaired, do not drive. Read MCPH’s guide to medical cannabis and driving in the UK for the broader legal and safety context.
What this article is not saying
This article is not saying medical cannabis is safe to combine with antidepressants or anxiety medicines. It is not saying those medicines automatically block a prescription. It is not recommending CBD, THC, flower, oil, extracts, a clinic, a pharmacy, a dose, a route or a medicine change.
It is saying that antidepressants, benzodiazepines, mirtazapine, anxiety medicines, alcohol, supplements, non-prescribed cannabis, mood changes, panic, psychosis history and substance-use history belong in the open. The useful next step is disclosure and clinician review, not self-management.
Sources
- NHS: Medical cannabis
- NHS: Lorazepam
- NHS: Common questions about lorazepam
- NHS: Common questions about duloxetine
- NHS: Common questions about mirtazapine
- NICE: Cannabis-based medicinal products, NG144
- NHS England: Cannabis-based products for medicinal use
- GMC: Information for doctors on cannabis-based products for medicinal use
- CQC: Cannabis-based medicinal products: what CQC looks for when providers register
- RCPsych: Cannabis and mental health
- GOV.UK: Drug driving law
